Chosa Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Chosa Oncology has a total shareholder equity of SEK19.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK21.8M and SEK2.0M respectively. Chosa Oncology's EBIT is SEK7.3M making its interest coverage ratio 13. It has cash and short-term investments of SEK11.1M.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | 13x |
| Cash | SEK 11.14m |
| Equity | SEK 19.81m |
| Total liabilities | SEK 1.95m |
| Total assets | SEK 21.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: W5L's short term assets (SEK11.6M) exceed its short term liabilities (SEK2.0M).
Long Term Liabilities: W5L has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: W5L is debt free.
Reducing Debt: W5L has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable W5L has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: W5L is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 155.8% per year.